Here, we used PEG-FUD peptide to target FN (42), revealing that it preferentially localizes to regions morphologically consistent with fibroblastic foci in the human IPF lung ex vivo and the early time points after bleomycin-induced lung injury in mice. Here, FN1 is linked to idiopathic pulmonary fibrosis.